A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers

A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers

Paul M Karpecki,1,2 Sidney L Weiss,3 William G Kramer,4 Patrick O’Connor,5 David Evans,6 Josh Johnston,7 April L Jasper,8 Angela Justice,9 Abayomi B Ogundele,9 Doug Devries10 1Kentucky Eye Institute, Lexington, KY, USA; 2Gaddie Eye Centers, Louisville, KY, USA; 3i-novion, Inc., Randolph,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Karpecki PM, Weiss SL, Kramer WG, O'Connor P, Evans D, Johnston J, Jasper AL, Justice A, Ogundele AB, Devries D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
dry eye disease
cyclosporine
pharmacokinetic
systemic exposure
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/f8bebe97bc844400bd124f7bbbe0f33a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f8bebe97bc844400bd124f7bbbe0f33a

Ejemplares similares